SCHEMBL19405245

SCHEMBL19405245

Cc1ccccc1CCNCC(C)C

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ TAAR1 Q96RJ0 2/20 0.47
▸ CHRM2 P08172 2/20 0.44
▸ ADRB2 P07550 2/20 0.40
▸ ADRB1 P08588 2/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ MPO P05164 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.36
▸ DNM1 Q05193 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21243271 0.84 CHRM2 (0.59) TAAR1CHRM2MEN1KMT2AMAPT
SCHEMBL23374589 0.81 CHRM2 (0.56) ALDH1A1TAAR1CHRM2MEN1KMT2A
SCHEMBL31558942 0.81 CHRM2 (0.56) ALDH1A1TAAR1CHRM2MEN1KMT2A
SCHEMBL22762048 0.80 TAAR1 (0.59) ALDH1A1CYP1A2CYP2C19TAAR1CHRM2
SCHEMBL22762068 0.80 TAAR1 (0.59) ALDH1A1CYP1A2CYP2C19TAAR1CHRM2
SCHEMBL10725177 0.79 TAAR1 (0.52) TAAR1CHRM2MEN1KMT2AMAPT
SCHEMBL20615042 0.77 CHRM2 (0.52) TAAR1CHRM2MEN1KMT2AMAPT
SCHEMBL21345586 0.77 TAAR1 (0.50) ALDH1A1TAAR1CHRM2ADRB2ADRB1
SCHEMBL9201570 0.76 CHRM2 (0.50) ALDH1A1TAAR1CHRM2MEN1KMT2A
SCHEMBL13416723 0.75 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C19TAAR1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022120207-A1 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX UNIVERSITY OF MARYLAND, BALTIMORE (US) 2022-06-09 — — WO disclosed
WO-2020247860-A1 BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX UNIVERSITY OF MARYLAND, BALTIMORE (US) 2020-12-10 — — WO disclosed
US-20170275272-A1 6-HYDROXY-4-OXO-1,4-DIHYDROPYRIMIDINE-5-CARBOXAMIDES AS APJ AGONISTS BRISTOL-MYERS SQUIBB COMPANY 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275272-A1 6-HYDROXY-4-OXO-1,4-DIHYDROPYRIMIDINE-5-CARBOXAMIDES AS APJ AGONISTS AP2A1, P2RX5, AP3M1 ALDH1A1 448/4885CYP1A2 645/4885CYP2C19 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback